Rapid antigen screening of asymptomatic people as a public health tool to combat COVID-19
Open Access
- 2 March 2021
- journal article
- research article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (13) , E449-E452
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Support for self-isolation is critical in covid-19 responseBMJ, 2021
- Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral CultureClinical Infectious Diseases, 2021
- Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2Science, 2021
- SARS-CoV-2 Transmission From People Without COVID-19 SymptomsJAMA Network Open, 2021
- Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020MMWR. Morbidity and Mortality Weekly Report, 2021
- Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical periodInternational Journal of Infectious Diseases, 2021
- Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptomsJournal of Clinical Virology, 2020
- Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce OutbreaksClinical Infectious Diseases, 2020
- Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom OnsetJAMA Internal Medicine, 2020
- Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997.American Journal of Public Health, 1999